Page last updated: 2024-09-05
sb 216763 and curcumin
sb 216763 has been researched along with curcumin in 1 studies
Compound Research Comparison
Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (curcumin) | Trials (curcumin) | Recent Studies (post-2010) (curcumin) |
---|---|---|---|---|---|
342 | 0 | 225 | 16,336 | 593 | 12,705 |
Protein Interaction Comparison
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jeong, CW; Jeong, HJ; Kim, SJ; Lee, CS; Lee, SH; Yoo, KY | 1 |
Other Studies
1 other study(ies) available for sb 216763 and curcumin
Article | Year |
---|---|
Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cardiotonic Agents; Curcumin; Drug Therapy, Combination; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Ventricles; Indoles; Male; Maleimides; MAP Kinase Signaling System; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley | 2012 |